Linge

AMRA Biomarkers Indicate Individuals with CVD and T2D Have Faster Muscle Deterioration than Metabolically Disease-Free People -- AMRA Medical to Present Data at SCWD

Retrieved on: 
Thursday, June 23, 2022
Wasting, Conference, Lists of diseases, MFI, Cachexia, Longevity, CVD, UK Biobank, Biobank, Magnetic resonance imaging, T2D, Linge, Research, Cardiovascular disease, MRI, Mortality, Muscle, Journal of Cachexia, Sarcopenia and Muscle, Sarcopenia, Biomarker, CEO, Health, Ageing, Physician, Multimedia, Medical imaging

LINKÖPING, Sweden, June 23, 2022 /PRNewswire/ -- AMRA Medical will present the results of their recent study using magnetic resonance imaging (MRI) to measure muscle composition changes in individuals with metabolic disorders at the 2022 SCWD Conference. AMRA's research shows they can observe significant changes in muscle composition measurements after two years of aging. The results indicate that individuals with metabolic disorders experience more rapid wasting and that diseases may have a disease-specific wasting profile. Researchers can use AMRA's muscle-monitoring biomarkers to further study the progression, severity, and risks of metabolic diseases. This research could also have clinical implications, which could further enhance the utility of AMRA's currently available clinical service offerings that help monitor an individual's health and wellness.

Key Points: 
  • LINKPING, Sweden, June 23, 2022 /PRNewswire/ -- AMRA Medical will present the results of their recent study using magnetic resonance imaging (MRI) to measure muscle composition changes in individuals with metabolic disorders at the 2022 SCWD Conference .
  • The results indicate that individuals with metabolic disorders experience more rapid wasting and that diseases may have a disease-specific wasting profile.
  • Researchers can use AMRA's muscle-monitoring biomarkers to further study the progression, severity, and risks of metabolic diseases.
  • Notably, the rate of muscle wasting was distinct for each group, with CVD being associated with the most rapid muscle wasting profile followed by T2D.

Christian Linge Makes First $250,000 Donation to the American Cancer Society's Cancer Crypto Fund, Will Be Honored As First Visionary Donor for Groundbreaking Gift

Retrieved on: 
Tuesday, October 12, 2021
Crypto, Bitcoin, Ethereum, Dogecoin, Litecoin, COVID-19, American Cancer Society, Cancer, Linge, Senior, ACS, Research, Pharmaceutical industry, Cryptocurrency

ATLANTA, Oct. 12, 2021 /PRNewswire/ -- The American Cancer Society (ACS) today recognized Christian Linge of SafeBreast communities from Oslo, Norway, for his precedent-setting $250,000 donation to the ACS Cancer Crypto Fund.

Key Points: 
  • ATLANTA, Oct. 12, 2021 /PRNewswire/ -- The American Cancer Society (ACS) today recognized Christian Linge of SafeBreast communities from Oslo, Norway, for his precedent-setting $250,000 donation to the ACS Cancer Crypto Fund.
  • Linge is already listed on the ACS Crypto Cancer Fund Wall of Honor for an earlier gift of $10,000 or more on behalf of SafeBreast Communities.
  • "It is exciting to receive this generous and groundbreaking donation to the American Cancer Society Cancer Crypto Fund," said Ruth Ann Dailey, Senior Vice President, Philanthropy, for the American Cancer Society.
  • A complete list of accepted cryptocurrencies and an opportunity to donate to the Crypto Cancer Fund can be found at www.cancer.org/cryptofund .